SUSTAINABLE GROWTH
Our Strategy
Our corporate strategy follows our philosophy and emphasizes on vertical integration and the development of internal capabilities that fuel the company's sustainable growth. We have been developing our footprint in Greece and the global markets across our operations domains in Pharmaceuticals and Diagnostics. Pharmazac focuses on combining its in-house R&D and technology capabilities alongside the development of strong partnerships with leading firms in the field.
LOOKING AHEAD
Our PHARMAZAC 50 Vision
Pharmazac has recently unfolded its new vision for the future which encapsulates an ambitious set of investments in spin-off projects, IP development and new brownfield and Greenfield projects. We aim to become a global players in pharmaceuticals and diagnostics, bringing in the market a series of innovative formulations and unique solutions within a complete manufacturing ecosystem.
INNOVATIVE PIPELINE
Our Research & Development
Pharmazac operates its R&D centers with emphasis on sustaining a strong output of pharmaceutical formulations and diagnostic solutions. In 2025 the setup of a new R&D GMP center, including a unique pilot production site boosted the R&D performance, allowing the enrichment of the international portfolio with many new generics and innovative generics products. Our growing team of experts in formulation, analytical development, patents and manufacturing develop more than five products per year, alongside the development of radiopharmaceutical and injectables, through CDO collaborations. Pharmazac is investing on average 10% of its annual revenue in developing its dossiers portfolio.
